FDA Approves New Intravenous Monkeypox Drug Treatment From PFIZER-Linked SIGA Technologies

Pfizer is apparently at it again, conveniently hitting another grand slam with another perfectly timed drug release for the latest viral outbreak sweeping the west – monkeypox. After hitting it out of the park with their experimental mRNA Covid vaccine – typically what would be considered a once-in-a-lifetime development that’s cashing the company out to … Continue reading FDA Approves New Intravenous Monkeypox Drug Treatment From PFIZER-Linked SIGA Technologies